Sign in

CIK 0001840233

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Xilio Therapeutics, Inc.

Sign in to watch
Ticker
XLO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
851623397
Phone
+1 617-833-1027
Business address
828 WINTER STREET, WALTHAM, MA, 02451
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-10-26 Merck KGaA 10% owner Conversion +416,060 416,060
2021-10-26 Merck KGaA 10% owner Conversion +264,765 680,825
2021-10-26 Merck KGaA 10% owner Conversion · Series B Preferred Stock −3,952,568 0
2021-10-26 Merck KGaA 10% owner Conversion · Series C Preferred Srock −2,515,271 0

Page 1 of 1 · 4 trades